Related Experiment Video
Updated: Jan 24, 2026

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
Published on: August 13, 2017
Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration
Andrew R Clark1, Michael Ohlmeyer2
1Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.
Abstract:
Protein phosphatase 2A (PP2A) is a highly complex heterotrimeric enzyme that catalyzes the selective removal of phosphate groups from protein serine and threonine residues. Emerging evidence suggests that it functions as a tumor suppressor by constraining phosphorylation-dependent signalling pathways that regulate cellular transformation and metastasis. Therefore, PP2A-activating drugs (PADs) are being actively sought and investigated as potential novel anti-cancer treatments. Here we explore the concept that PP2A also constrains inflammatory responses through its inhibitory effects on various signalling pathways, suggesting that PADs may be effective in the treatment of inflammation-mediated pathologies.
Insights
Protein phosphatase 2A (PP2A) acts as a tumor suppressor by regulating cell signaling. New research suggests PP2A also controls inflammation, indicating PP2A-activating drugs could treat both cancer and inflammatory diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Protein phosphatase 2A (PP2A) is a crucial enzyme for dephosphorylation.
- PP2A is recognized for its tumor suppressor role by inhibiting oncogenic signaling pathways.
- Its role in inflammation is less understood but increasingly recognized.
Purpose of the Study:
- To explore the role of PP2A in regulating inflammatory responses.
- To investigate the potential of PP2A-activating drugs (PADs) in treating inflammation-mediated diseases.
Main Methods:
- Literature review and conceptual analysis of PP2A's signaling roles.
- Examination of PP2A's inhibitory effects on key inflammatory pathways.
Main Results:
- PP2A dephosphorylates key proteins involved in cellular transformation and metastasis.
- PP2A also targets signaling pathways critical for inflammatory responses.
- Evidence suggests PP2A acts as a negative regulator of inflammation.
Conclusions:
- PP2A's dual role in suppressing cancer and inflammation is highlighted.
- PADs represent a promising therapeutic strategy for both cancer and inflammatory conditions.
- Further research into PP2A modulators for inflammatory diseases is warranted.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Inflammation
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Microorganisms in Medicine and Therapeutics

